Amazon Archives - Page 2 of 3 - Medical Design Sourcing

Medtronic and Amazon plan colorectal cancer screenings in underserved communities

Medtronic’s GI Genius intelligent endoscopy module [Image courtesy of Medtronic]Medtronic (NYSE:MDT) and Amazon (NASDAQ:AMZN) today announced their plans to donate 50 Medtronic GI Genius modules to endoscopy centers serving low-income and underserved communities across the U.S.

One of the goals is to improve the detection of polyps that can lead to colorectal cancer, which is the most common cancer among adults in the U.S. — and the third deadliest.

Fridley, Minnesota-based Medtronic launched the GI Genius intelligent endoscopy module in 2019 and secured FDA authorization for marketing last year. Powered by artificial intelligence, the system automatically detects colorectal polyps of varying shapes and sizes in real-time. Medtronic said the system increases the absolute detection rate by up to 14.4%, with each 1% increase cutting a patient’s risk of colorectal cancer by 3%.

Get the full story at our sister publication, Medical Design & Outsourc…

Medtronic and Amazon plan colorectal cancer screenings in underserved communities

Medtronic’s GI Genius intelligent endoscopy module [Image courtesy of Medtronic]

Medtronic (NYSE:MDT) and Amazon (NASDAQ:AMZN) today announced their plans to donate 50 Medtronic GI Genius modules to endoscopy centers serving low-income and underserved communities across the U.S.

One of the goals is to improve the detection of polyps that can lead to colorectal cancer, which is the most common cancer among adults in the U.S. — and the third deadliest.

Fridley, Minnesota-based Medtronic launched the GI Genius intelligent endoscopy module in 2019 and secured FDA authorization for marketing last year. Powered by artificial intelligence, the system automatically detects colorectal polyps of varying shapes and sizes in real-time. Medtronic said the system increases the absolute detection rate by up to 14.4%, with each 1% increase cutting a patient’s risk of colorectal cancer by 3%.

“T…

Herbal supplements recalled as a result of undeclared sildenafil and tadalafil

Image courtesy of Pexels

Amazon has informed the herbal supplement company Celebrate Today (Brentwood, New York) that its Red Mammoth pills were tainted with sildenafil and tadalafil, both of which are FDA-regulated drugs for erectile dysfunction and other conditions.

Similarly, Amazon announced that a lab identified tadalafil in the “Red Pill” capsules from a company known as Your Favorite Shop (Jackson, New Jersey).

FDA has announced that Celebrate Today and Your Favorite Shop are carrying out a voluntary nationwide recall of the pills.

Last week, FDA announced several similar recalls affecting supplements sold on Amazon.

A press release from the FDA notes that the PDE-5 inhibitors sildenafil and tadalafil have been associated with drug-drug interactions. For instance, individuals with metabolic disease taking nitrates such as nitroglycerin may suffer potentially life-threatening drops…

Amazon launches U.S. telehealth service, plans in-person service rollout in more than 20 cities

Amazon announced that it made its virtual health services available nationwide with plans for a large rollout of in-person services this year.

The company launched Amazon Care in September 2019 to combine virtual care and in-person services, with the latest expansion making the services available nationwide.

According to a news release, Amazon will look to rollout in-person services in more than 20 new cities this year as it invests in the growth of its clinical care team and in-person care services in the country. The company points to the COVID-19 pandemic as a driving factor behind the demand for bringing care to patients’ homes, through both virtual and in-home means.

The company’s in-person services are already available in Seattle, Baltimore, Boston, Dallas, Austin, Los Angeles, Washington, D.C., and Arlington. The planned 2022 expansion includes major metropolitan areas such as San Francisco, Miami, Chicago and New York City.

Ne…

Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam [Photo courtesy of Johnson & Johnson]Cloud-connected medical devices already collect and analyze data, talk to each other and use artificial intelligence to improve patient care, but how much more might be possible in the not-so-distant future? Surgery simulations? Smart ambulances? Full-body scanners? One-click healthcare?

I’ve been exploring that question for an upcoming edition of Medical Design & Outsourcing magazine — and asked two leaders in the Johnson & Johnson (NYSE:JNJ) medical device business to put their imagination to work as they embark on a cloud partnership with Microsoft (NASDAQ:MSFT). This second part of the conversation (read the first part here) also discusses the regulatory aspect of cloud-connected medical devices and how the medtech industry can keep advancing the technology.

Johnson & Johnson Group CIO and Global Vice President of Medical Devices Larry Jone…

Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam [Photo courtesy of Johnson & Johnson ]

Cloud-connected medical devices already collect and analyze data, talk to each other and use artificial intelligence to improve patient care, but how much more might be possible in the not-so-distant future? Surgery simulations? Smart ambulances? Full-body scanners? One-click healthcare?

I’ve been exploring that question for an upcoming edition of Medical Design & Outsourcing magazine, and asked two leaders in the Johnson & Johnson (NYSE:JNJ) medical device business to put their imagination to work as they embark on a cloud partnership with Microsoft (NASDAQ:MSFT). This second part of the conversation (read the first part here) also discusses the regulatory aspect of cloud-connected medical devices and how the medtech industry can keep advancing the technology.

This conversatio…

MedTech 100 roundup: Industry reaches another high point

The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. Following a slight dip earlier this month, the industry continues to tick up to new heights.

Medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry remains well above the marks set around the height of the pandemic, having registered a 31.1% increase from the pre-pandemic high of 92.32 (set on Feb. 19, 2020). Moreover, it remains well ahead of the mid-pandemic low of 62.13 (March 23, 2020) as well, totaling a 94.8% ascent above that point.

The industry’s performance fell in line with the overall markets this past week as the S&P 500 I…

Amazon makes moves for a major medical diagnostics play

Amazon (NASDAQ: AMZN) wants to hire key employees to expand its medical diagnostics operations on a global scale, which very well could grow beyond COVID-19 testing.

Senior-level job postings offer a glimpse of the notoriously secretive and ambitious tech company’s global aspirations for medical diagnostics. Just this week, Amazon put a call out for a medical regulatory officer to be based in Seattle, where the online retailer and cloud computing company is headquartered.

“Regular testing on a global scale across all industries would both help keep people safe and help get the economy back up and running,” Amazon said in the job description, mirroring language in others posted earlier in August. “But, for this to work, we as a society would need vastly more testing capacity than is currently available. Until we have an effective vaccine available in billions of doses, high-volume testing capacity would be of great help, but getting that done will take c…

Amazon makes moves for a major medical diagnostics play

Amazon Diagnostics’ lab in Hebron, Kentucky [image courtesy of Amazon]

Amazon (NASDAQ: AMZN) wants to hire key employees to expand its medical diagnostics operations on a global scale, which very well could grow beyond COVID-19 testing.

Senior-level job postings offer a glimpse of the notoriously secretive and ambitious tech company’s global aspirations for medical diagnostics. Just this week, Amazon put a call out for a medical regulatory officer to be based in Seattle, where the online retailer and cloud computing company is headquartered.

“Regular testing on a global scale across all industries would both help keep people safe and help get the economy back up and running,” Amazon said in the job description, mirroring language in others posted earlier in August. “But, for this to work, we as a society would need vastly more testing capacity than is currently available. Until we have an effective…

GE Healthcare, Baxter among medtech giants inking deals with Amazon Web Services

GE Healthcare (NYSE:GE) and Baxter (NYSE:BAX) are both collaborating with Amazon Web Services for AI and cloud-based solutions.

The strategic collaborations aim to drive the companies’ digital presences forward, with GE Healthcare saying that it will work with AWS to deliver AI and cloud-based imaging solutions, integrated data and clinical and operational insights to hospitals and healthcare providers.

Get the full story at our sister site, Medical Design & Outsourcing.

GE Healthcare, Baxter among medtech giants inking deals with Amazon Web Services

GE Healthcare (NYSE:GE) and Baxter (NYSE:BAX) are both collaborating with Amazon Web Services for AI and cloud-based solutions.

The strategic collaborations aim to drive the companies’ digital presences forward, with GE Healthcare saying that it will work with AWS to deliver AI and cloud-based imaging solutions, integrated data and clinical and operational insights to hospitals and healthcare providers.

GE Healthcare said in a news release that it plans to offer its AI-based imaging applications and Edison Health Services platform on AWS to help transition healthcare providers around the world from the traditional care delivery model in the hospital settings to a decentralized model that is virtual and distributed. The company noted that the COVID-19 pandemic accelerated the remote care trend and the cloud will enable the care delivery model’s transformation.

Baxter plans to use its collaboration with AWS to develop new digital health solutio…

MedTech 100 roundup: Significant uptick for industry

The up-and-down nature of the medtech industry continues to carry through 2021, with a recent dip now followed by a rapid ascent.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 11) at 109.63 points, producing a 2.5% rise from the 106.96-point mark set one week prior (June 4).

It provides a welcome sight after the industry’s progress came to a halt with a -1.4% dip the week before last. The index remains in a position to produce another upswing after demonstrating signs of picking up again when April brought the industry’s all-time best performance.

Even with setbacks that slowed the industry recently, medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 18.8% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus a 76.5% increase from the mid-pandemic low…